Memory loss could be an indication of Parkinson’s

News

Author: Joe McAweaneyPublished: 24 December 2018

Prep: Cook: Serves:

Memory loss could be an early indication of Parkinson’s disease, according to a recent study by researchers in France.

The study, published in medical journal ‘Behavioural Brain Research’, suggests that neurodegeneration in the substantia nigra – a critical area of the brain involved in Parkinson’s – could lead to memory loss and the subsequent development of the condition.

As part of the study, a group of rats were administered with a toxin that damages neurons in the brain – while another group were injected with Parkinson’s medication over 10 consecutive days.

Various behavioural tests were then carried out on both groups to assess the animals’ movement, social interaction and motor function.

Results showed that the group of rats that had been given the toxin displayed significant memory loss compared to those who had been exposed to the Parkinson’s medication.

To read more on this topic click here.

To learn more about memory loss and Parkinson’s, please visit the EPDA website here.

Repurposed cancer drug shows promise for Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Europe

Copenhagen Unity Walk: fun for all the family

The annual Parkinson’s fundraiser in Denmark

Episodes

Podcast: Lessons learned from the pandemic

How has the Parkinson’s disease community been impacted by Covid-19?

‘Parkinson’s will double by 2040: Are We Ready?’

Is there a link between Parkinson’s disease and blood vessel dysfunction?

Scientists in Slovakia have investigated the link between blood vessel dysfunction and Parkinson’s – and found that dopamine agonists may have an impact. The team studied the function of the endothelium – a membrane which lines the heart and blood vessels and helps control blood fluidity – in 41 people with the condition and 41 people without. Endothelial function was then measured through a parameter that assessed how easily blood could flow through the vessels. The results showed that while more people with Parkinson’s had endothelial dysfunction compared to those without, the difference did not reach statistical significance. However, the researchers noted that the findings suggested “an association between smoking, dopamine agonists, and impaired endothelial function” in those with the condition. Outlining the study’s limitations, the team noted that more research is needed to explore this potential link.

New swab test may help with Parkinson’s disease diagnosis

Researchers at the University of Manchester, UK, have drawn on one woman’s sense of smell to develop a swab test that may be used to detect Parkinson’s. The scientists used the test to analyse sebum (a type of oily substance on the skin) in 79 people with Parkinson’s and a control group of 71 healthy individuals. The team identified more than 4,000 different compounds in the participant samples – including 500 that were unique to those living with the condition. The test was developed with the help of Joy Milne from Perth, Scotland, whose unique sense of smell meant that she noticed a change in her late husband Les’s odour twelve years before he was diagnosed with Parkinson’s. Speaking to the BBC, Professor Perdita Barran, who led the research, described the test as potentially “transformative” – and said that the team hopes to roll the test out to people in…

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

A biobank is a collection of biological samples and data designed to be used for research. Now, researchers in Australia are working to build a biobank for Parkinson’s. As part of the project, the scientists are conducting scans of people that have been injected with fluorodopa – a substance that highlights dopamine in the brain. Participants include people living with Parkinson’s and a control group of people without the condition. The resulting database of scans will be used to create a national biobank that aims to inform treatment and research into the condition. Commenting on the study, Olivia Nasser – executive director at the Hospital Research Foundation, which is helping to fund the research – said, “Once we build up the biobank of scans, it can actually be used as an effective way to treat Parkinson’s.” The researchers encourage people with and without Parkinson’s to take part in the trial.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Memory loss could be an indication of Parkinson’s

News

Author: Joe McAweaneyPublished: 24 December 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Europe

Copenhagen Unity Walk: fun for all the family

sponsored article

Episodes

Podcast: Lessons learned from the pandemic

Resources & Tools

‘Parkinson’s will double by 2040: Are We Ready?’

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Memory loss could be an indication of Parkinson’s

News

Author: Joe McAweaneyPublished: 24 December 2018

Last Month

Next Month

Share this story

Comments

Related articles

Europe

Copenhagen Unity Walk: fun for all the family

sponsored article

Episodes

Podcast: Lessons learned from the pandemic

Resources & Tools

‘Parkinson’s will double by 2040: Are We Ready?’

Is there a link between Parkinson’s disease and blood vessel dysfunction?

New swab test may help with Parkinson’s disease diagnosis

Could a national biobank help inform the future of Parkinson’s disease treatment in Australia?

{title}

Subscribe

Sign in